EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates

Lina Rivas iD, Lorena Díaz iD, Valeria Quiroz, Jose R W Martinez iD, Camila Solar iD, Ayesha Khan, Katherine Soto, Pamela Rojas Soto, Maria-Paz Acuña, María L Rioseco, Margareta Mühlhauser, Yehudit Bergman und 3 weitere

Journal of Clinical Microbiology · 11.11.2026 · 64 (11)

DOI: 10.1128/jcm.00797-26 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 11.11.2026. Verfasst von Lina Rivas und 14 weiteren Autor:innen. Beteiligte Einrichtung: Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad …. Hauptthemen laut MEDLINE: Aztreonam, beta-Lactamases, Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aztreonam-avibactam (ATM-AVI) is a promising therapeutic for New Delhi metallo-β-lactamase-producing Enterobacterales (NDM-E) infections. We evaluated the performance of disk diffusion and gradient diffusion methods compared with reference broth microdilution (BMD) for ATM-AVI susceptibility testing. A total of 245 non-duplicate NDM-E isolates were included, collected from unique patients at hospitals in Chile and the United States between 2022 and 2024. Nine ATM-AVI non-susceptible isolates from a separate collection were added to enrich for resistant isolates, yielding a total of 254 isolates. Reference BMD was performed according to Clinical and Laboratory Standards Institute (CLSI) criteria. ATM-AVI disk diffusion and two gradient diffusion methods (ETEST and MIC Test Strip) were evaluated against BMD using categorical agreement, essential agreement, and CLSI-defined error rates. All 245 NDM-E isolates were susceptible to ATM-AVI (MIC ≤4/4 µg/mL), with MIC₅₀/₉₀ values of 0.25/4 and 1/4 µg/mL, respectively. The collection consisted of Klebsiella pneumoniae (71%), Enterobacter cloacae complex (21%), and Escherichia coli (8%). Predominant NDM alleles included bla NDM-1 and bla NDM-7 . Disk diffusion demonstrated 98% categorical agreement (250/254), with four minor errors. Both gradient diffusion methods achieved 99% categorical agreement (252/254), with no very major or major errors and two minor errors. Essential agreement was 67% for ETEST and 85% for MIC Test Strip; both methods tended to underestimate ATM-AVI MICs relative to BMD. ATM-AVI demonstrated robust in vitro activity against a contemporary NDM-E cohort. Disk and gradient diffusion methods are practical alternatives to BMD for clinical laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aztreonambeta-LactamasesAnti-Bacterial AgentsEnterobacteriaceaeAzabicyclo CompoundsHumansMicrobial Sensitivity TestsEnterobacteriaceae InfectionsUnited StatesChileDrug Combinations

Stichwörter der Autor:innen

Enterobacter cloacae complexEscherichia coliKlebsiella pneumoniaeantimicrobial resistancecarbapenemases

Substanzen

Aztreonambeta-LactamasesAnti-Bacterial AgentsAzabicyclo Compoundsavibactamaztreonam, avibactam drug combinationDrug Combinations

Autor:innen und Institutionen

  • Genomics & Resistant Microbes Group (GeRM), Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Multidisciplinary Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile.
  • Surveillance, Epidemiology, and New Technologies for Infectious Emerging Threats (SENTINET), Santiago, Chile.
  • UC Irvine School of Medicine, Irvine, California, USA.
  • Hospital Padre Hurtado, Santiago, Chile.
  • Pontificia Universidad Católica de Chile, Santiago, Chile.

ORCID-Profile: Lina Rivas, Lorena Díaz, Jose R W Martinez, Camila Solar, Pranita D Tamma

Zitieren

APA

Rivas, L., Díaz, L., Quiroz, V., Martinez, J. R. W., Solar, C., Khan, A., Soto, K., Rojas Soto, P., Acuña, M. P., Rioseco, M. L., Mühlhauser, M., Bergman, Y., García, P., Munita, J. M., & Tamma, P. D. (2026). Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates. Journal of Clinical Microbiology, 64(11). https://doi.org/10.1128/jcm.00797-26

Vancouver

Rivas L, Díaz L, Quiroz V, Martinez JRW, Solar C, Khan A, et al. Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates. Journal of Clinical Microbiology. 2026;64(11). doi:10.1128/jcm.00797-26

BibTeX
@article{Rivas2026,
  author = {Rivas, Lina and Díaz, Lorena and Quiroz, Valeria and Martinez, Jose R W and Solar, Camila and Khan, Ayesha and Soto, Katherine and Rojas Soto, Pamela and Acuña, Maria-Paz and Rioseco, María L and Mühlhauser, Margareta and Bergman, Yehudit and García, Patricia and Munita, José M and Tamma, Pranita D},
  title = {Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {11},
  doi = {10.1128/jcm.00797-26}
}
Kostenlos starten →